CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Multicohort Study to Evaluate Lorigerlimab in Participants With Advanced Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06730347
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:17.606680+00:00
Published At: 2026-03-05T00:00:00+00:00
Record Updated At: 2026-03-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Platinum-resistant Ovarian Cancer", "Platinum-Resistant Fallopian Tube Carcinoma", "Platinum-Resistant Primary Peritoneal Carcinoma", "Clear Cell Adenocarcinoma of Ovary", "Clear Cell Adenocarcinoma of Vulva", "Clear Cell Adenocarcinoma of Vagina", "Clear Cell Adenocarcinoma of Cervix", "Clear Cell Adenocarcinoma of Uterus", "Clear Cell Adenocarcinoma of Fallopian Tube", "Clear Cell Adenocarcinoma of Peritoneum", "Endometrial Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-03-05"
protocolSection.identificationModule.nctId: "NCT06730347"
protocolSection.identificationModule.officialTitle: "A Phase 2 Multicohort Study to Evaluate Lorigerlimab in Participants With Advanced Solid Tumors"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.